Should we have any predictive marker for estimating the severity of community-acquired pneumonia at admission?
Abstract
Keywords
Supporting Institution
References
- Harris M, Clark J, Coote N, et al. British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for managing community-acquired pneumonia in children: update 2011. Thorax 2011; 66: 1-23.
- Wardlaw T, Salama P, Johansson EW, Mason E. Pneumonia: the leading killer of children. Lancet 2006; 368: 1048-50.
- Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 2008; 86: 408-16.
- Chalmers JD, Singanayagam A, Hill AT. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Am J Med 2008; 121: 219-25.
- Krüger S, Ewig S, Marre R, et al. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes. Eur Respir J 2008; 31: 349-35.
- Hangul M, Ozturk D, Keti DB, Demirkan FG, Kose M. Plasma kallistatin levels in children with community-acquired pneumonia. Pediatr Allergy Immunol Pulmonol 2018; 31: 146-50.
- Florin TA, Ambroggio L, Brokamp C, et al. Proadrenomedullin predicts severe disease in children with suspected community-acquired pneumonia. Clin Infect Dis 2021; 73: 524-30
- Esposito S, Di Gangi M, Cardinale F, et al. Sensitivity and Specificity of soluble triggering receptor expressed on myeloid cells-1, midregional proatrial natriuretic peptide and midregional proadrenomedullin for distinguishing etiology and to assess severity in community-acquired pneumonia. PLoS One 2016; 1: 0163262.
Details
Primary Language
English
Subjects
Health Care Administration
Journal Section
Research Article
Authors
Melih Hangül
*
Türkiye
Mehmet Köse
Türkiye
Hüseyin Pür
Türkiye
Murat Doğan
Türkiye
Emrah Türk
Türkiye
Ali Ersoy
Türkiye
Mehmet Adnan Öztürk
Türkiye
Publication Date
September 26, 2022
Submission Date
August 8, 2022
Acceptance Date
September 11, 2022
Published in Issue
Year 2022 Volume: 3 Number: 3






